1. Home
  2. PSFE vs BBNX Comparison

PSFE vs BBNX Comparison

Compare PSFE & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paysafe Limited

PSFE

Paysafe Limited

HOLD

Current Price

$9.11

Market Cap

422.8M

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$10.01

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSFE
BBNX
Founded
1996
2015
Country
United Kingdom
United States
Employees
2900
423
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
422.8M
493.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PSFE
BBNX
Price
$9.11
$10.01
Analyst Decision
Hold
Strong Buy
Analyst Count
4
10
Target Price
$8.69
$23.80
AVG Volume (30 Days)
316.9K
1.1M
Earning Date
05-13-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.15
$34.90
Revenue Next Year
$6.25
$34.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.95
$8.80
52 Week High
$16.49
$32.71

Technical Indicators

Market Signals
Indicator
PSFE
BBNX
Relative Strength Index (RSI) 63.87 40.77
Support Level $6.61 $9.36
Resistance Level $9.39 $11.92
Average True Range (ATR) 0.39 0.83
MACD 0.00 -0.14
Stochastic Oscillator 59.58 10.90

Price Performance

Historical Comparison
PSFE
BBNX

About PSFE Paysafe Limited

Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company's reportable segments are Merchant Solutions and Digital Wallets. The Merchant Solutions segment, which derives maximum revenue, services markets in North America, Canada and Europe. The Digital Wallets segment services markets in Europe, UK, North America and Latin America. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: